# Registry Study of Chinese Patients with Marginal Zone Lymphoma (MOTIVE)

> **NCT06534463** · — · RECRUITING · sponsor: **Ruijin Hospital** · enrollment: 500 (estimated)

## Conditions studied

- Marginal Zone Lymphoma

## Interventions

- **OTHER:** All treatment regimen selections and usage will be determined by the physician based on clinical practice and/or the respective drug labels in China.

## Key facts

- **NCT ID:** NCT06534463
- **Lead sponsor:** Ruijin Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-02
- **Primary completion:** 2029-03-01
- **Final completion:** 2029-09-01
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2024-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06534463

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06534463, "Registry Study of Chinese Patients with Marginal Zone Lymphoma (MOTIVE)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06534463. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*